# G.L. Pharma Deutschland GmbH

Company profile · SME (from the award notice)

- Legal form: GmbH
- Seat: Hamburg, Germany

Based on the notices and sources Inteliwert covers; not a complete record. Last checked 16 September 2026.

## Identifiers

Not found in the indexed notices.

## Track record in public tenders

Awards in the covered notices over the last 36 months, per CPV division.

No award found in the indexed notices of the last 36 months.

### Awards

- [Abschluss eines nicht-exklusiven Rabattvertrages gemäß § 130a Abs. 8 SGB V zwischen der IKK classic und der G.L. Pharma Deutschland GmbH zu Remosan](https://inteliwert.com/tender/opp_8CHYVB5V4J4WJS2PESVNYQK95P/abschluss-eines-nicht-exklusiven-rabattvertrages-gemaess-130a-abs-8-sgb-v-zwisch)  
  Buyer: IKK classic · Award value: €1 excl. VAT · Awarded: 16 September 2026 · CPV 33600000

## Certifications and prequalification

No certification or prequalification found in the covered sources.

A certification missing here is unknown, not absent.

## Website and LinkedIn

Not found in the indexed notices.

## Open tenders that might fit

*Possible match based on public information*

Companies Inteliwert knows from its sources, not the whole market. Inteliwert does not judge eligibility, fit or chances.

- [Open-House-Rabattverträge 2026-12](https://inteliwert.com/tender/opp_G18CBMR4JECDWVN44YGNMQVFX8/open-house-rabattvertraege-2026-12)  
  Open · SME (from the award notice) · New to public tenders · Buyer: Techniker Krankenkasse · Deadline: 31 Aug 2028, 23:58 (UTC+02:00) · [Official notice](https://oeffentlichevergabe.de/ui/de/notices/056cda04-c704-41df-abcd-5c61f58aff90), Last checked 7 Nov 2026, 20:30 (UTC+01:00)
  - Won a contract in CPV group 336 (2026-09-16): [Evidence](https://inteliwert.com/tender/opp_8CHYVB5V4J4WJS2PESVNYQK95P/abschluss-eines-nicht-exklusiven-rabattvertrages-gemaess-130a-abs-8-sgb-v-zwisch), checked 7 Nov 2026
  - Seat in the same district as the place of performance: [Evidence](https://inteliwert.com/company/org_YRDP130JYBMX0Y189BSK381E56), checked 7 Nov 2026
  - 1 award in this field in 36 months, from 1 buyer: [Evidence](https://inteliwert.com/tender/opp_8CHYVB5V4J4WJS2PESVNYQK95P/abschluss-eines-nicht-exklusiven-rabattvertrages-gemaess-130a-abs-8-sgb-v-zwisch), checked 7 Nov 2026
- [Open-House-Originale-Rabattverträge 2026-13 Etrasimod](https://inteliwert.com/tender/opp_AP39JB1PFXYPDRSBZHZ0JGBT7C/open-house-originale-rabattvertraege-2026-13-etrasimod)  
  Open · SME (from the award notice) · New to public tenders · Buyer: Techniker Krankenkasse · Deadline: 31 Oct 2028, 23:58 (UTC+01:00) · [Official notice](https://oeffentlichevergabe.de/ui/de/notices/9dcbc02e-cd8c-480d-9b26-5ecbf67ce9ee), Last checked 7 Nov 2026, 13:30 (UTC+01:00)
  - Won a contract in CPV group 336 (2026-09-16): [Evidence](https://inteliwert.com/tender/opp_8CHYVB5V4J4WJS2PESVNYQK95P/abschluss-eines-nicht-exklusiven-rabattvertrages-gemaess-130a-abs-8-sgb-v-zwisch), checked 7 Nov 2026
  - Seat in the same district as the place of performance: [Evidence](https://inteliwert.com/company/org_YRDP130JYBMX0Y189BSK381E56), checked 7 Nov 2026
  - 1 award in this field in 36 months, from 1 buyer: [Evidence](https://inteliwert.com/tender/opp_8CHYVB5V4J4WJS2PESVNYQK95P/abschluss-eines-nicht-exklusiven-rabattvertrages-gemaess-130a-abs-8-sgb-v-zwisch), checked 7 Nov 2026
- [Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Thalidomid, ATC L04AX02 f. d. Z. 01.11.26-31.10.28 (zzgl. V.-Option 1x12 Mon)](https://inteliwert.com/tender/opp_63DZF7ZY03CZ5J0AS6Q8BBY260/abschluss-einer-nicht-exklusiven-rabattvereinbarung-nach-130a-abs-8-sgb-v-zum-wi)  
  Open · SME (from the award notice) · New to public tenders · Buyer: DAK-Gesundheit · Deadline: 5 Sept 2029, 12:00 (UTC+02:00) · [Official notice](https://oeffentlichevergabe.de/ui/de/notices/57b4aaef-861a-411a-a1ed-3f9d74bd31c5), Last checked 7 Nov 2026, 13:30 (UTC+01:00)
  - Won a contract in CPV group 336 (2026-09-16): [Evidence](https://inteliwert.com/tender/opp_8CHYVB5V4J4WJS2PESVNYQK95P/abschluss-eines-nicht-exklusiven-rabattvertrages-gemaess-130a-abs-8-sgb-v-zwisch), checked 7 Nov 2026
  - The contract value is close to the values of its past awards: [Evidence](https://inteliwert.com/tender/opp_63DZF7ZY03CZ5J0AS6Q8BBY260/abschluss-einer-nicht-exklusiven-rabattvereinbarung-nach-130a-abs-8-sgb-v-zum-wi), checked 7 Nov 2026
  - 1 award in this field in 36 months, from 1 buyer: [Evidence](https://inteliwert.com/tender/opp_8CHYVB5V4J4WJS2PESVNYQK95P/abschluss-eines-nicht-exklusiven-rabattvertrages-gemaess-130a-abs-8-sgb-v-zwisch), checked 7 Nov 2026
- [Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Nadroparin, ATC B01AB06 f. d. Z. 01.11.26-31.10.28 (zzgl. V.-Option 1x12 Mon)](https://inteliwert.com/tender/opp_BPHRYJF8BN1D4ZCNXEJYJGEEFE/abschluss-einer-nicht-exklusiven-rabattvereinbarung-nach-130a-abs-8-sgb-v-zum-wi)  
  Open · SME (from the award notice) · New to public tenders · Buyer: DAK-Gesundheit · Deadline: 5 Sept 2029, 12:00 (UTC+02:00) · [Official notice](https://oeffentlichevergabe.de/ui/de/notices/e047e95c-c1ed-40d3-9165-413d3e00e6ee), Last checked 7 Nov 2026, 13:30 (UTC+01:00)
  - Won a contract in CPV group 336 (2026-09-16): [Evidence](https://inteliwert.com/tender/opp_8CHYVB5V4J4WJS2PESVNYQK95P/abschluss-eines-nicht-exklusiven-rabattvertrages-gemaess-130a-abs-8-sgb-v-zwisch), checked 7 Nov 2026
  - The contract value is close to the values of its past awards: [Evidence](https://inteliwert.com/tender/opp_BPHRYJF8BN1D4ZCNXEJYJGEEFE/abschluss-einer-nicht-exklusiven-rabattvereinbarung-nach-130a-abs-8-sgb-v-zum-wi), checked 7 Nov 2026
  - 1 award in this field in 36 months, from 1 buyer: [Evidence](https://inteliwert.com/tender/opp_8CHYVB5V4J4WJS2PESVNYQK95P/abschluss-eines-nicht-exklusiven-rabattvertrages-gemaess-130a-abs-8-sgb-v-zwisch), checked 7 Nov 2026
- [Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Cinacalcet (ausschl. in der Normgröße N3), ATC H05BX01 f. d. Z. 01.11.26-31.10.28 (zzgl. V.-Option 1x12 Mon)](https://inteliwert.com/tender/opp_6EY1FSA283W1GRKYHV7RT25C9G/abschluss-einer-nicht-exklusiven-rabattvereinbarung-nach-130a-abs-8-sgb-v-zum-wi)  
  Open · SME (from the award notice) · New to public tenders · Buyer: DAK-Gesundheit · Deadline: 5 Sept 2029, 12:00 (UTC+02:00) · [Official notice](https://oeffentlichevergabe.de/ui/de/notices/f3caa4f1-1d07-455a-be52-e7f77a08c972), Last checked 7 Nov 2026, 13:30 (UTC+01:00)
  - Won a contract in CPV group 336 (2026-09-16): [Evidence](https://inteliwert.com/tender/opp_8CHYVB5V4J4WJS2PESVNYQK95P/abschluss-eines-nicht-exklusiven-rabattvertrages-gemaess-130a-abs-8-sgb-v-zwisch), checked 7 Nov 2026
  - The contract value is close to the values of its past awards: [Evidence](https://inteliwert.com/tender/opp_6EY1FSA283W1GRKYHV7RT25C9G/abschluss-einer-nicht-exklusiven-rabattvereinbarung-nach-130a-abs-8-sgb-v-zum-wi), checked 7 Nov 2026
  - 1 award in this field in 36 months, from 1 buyer: [Evidence](https://inteliwert.com/tender/opp_8CHYVB5V4J4WJS2PESVNYQK95P/abschluss-eines-nicht-exklusiven-rabattvertrages-gemaess-130a-abs-8-sgb-v-zwisch), checked 7 Nov 2026
- [Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Tacrolimus (ATC-Code nach WHO: L04AD02), mit Einschränkung auf die Darreichung](https://inteliwert.com/tender/opp_ZA59DPNY0KJ5CXKNNZRN879ZHC/abschluss-nicht-exkl-arzneimittel-rabattvereinb-nach-130a-abs-8-sgb-v-im-wege-ei)  
  Open · SME (from the award notice) · New to public tenders · Buyer: AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen · Deadline: 31 Oct 2027, 23:58 (UTC+01:00) · [Official notice](https://oeffentlichevergabe.de/ui/de/notices/a64d02bd-f659-4588-a63b-b72f53a3b369), Last checked 7 Nov 2026, 18:30 (UTC+01:00)
  - Won a contract in CPV group 336 (2026-09-16): [Evidence](https://inteliwert.com/tender/opp_8CHYVB5V4J4WJS2PESVNYQK95P/abschluss-eines-nicht-exklusiven-rabattvertrages-gemaess-130a-abs-8-sgb-v-zwisch), checked 7 Nov 2026
  - Seat in the same country as the place of performance: [Evidence](https://inteliwert.com/company/org_YRDP130JYBMX0Y189BSK381E56), checked 7 Nov 2026
  - 1 award in this field in 36 months, from 1 buyer: [Evidence](https://inteliwert.com/tender/opp_8CHYVB5V4J4WJS2PESVNYQK95P/abschluss-eines-nicht-exklusiven-rabattvertrages-gemaess-130a-abs-8-sgb-v-zwisch), checked 7 Nov 2026
- [Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Tacrolimus (ATC-Code nach WHO: L04AD02)](https://inteliwert.com/tender/opp_K5TZ3CS00WJ9TXXEG5CYPGRC2Q/abschluss-nicht-exkl-arzneimittel-rabattvereinb-nach-130a-abs-8-sgb-v-im-wege-ei)  
  Open · SME (from the award notice) · New to public tenders · Buyer: AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen · Deadline: 31 Oct 2027, 23:58 (UTC+01:00) · [Official notice](https://oeffentlichevergabe.de/ui/de/notices/71b5ba12-6e99-43dc-b8e8-18080892e397), Last checked 7 Nov 2026, 18:30 (UTC+01:00)
  - Won a contract in CPV group 336 (2026-09-16): [Evidence](https://inteliwert.com/tender/opp_8CHYVB5V4J4WJS2PESVNYQK95P/abschluss-eines-nicht-exklusiven-rabattvertrages-gemaess-130a-abs-8-sgb-v-zwisch), checked 7 Nov 2026
  - Seat in the same country as the place of performance: [Evidence](https://inteliwert.com/company/org_YRDP130JYBMX0Y189BSK381E56), checked 7 Nov 2026
  - 1 award in this field in 36 months, from 1 buyer: [Evidence](https://inteliwert.com/tender/opp_8CHYVB5V4J4WJS2PESVNYQK95P/abschluss-eines-nicht-exklusiven-rabattvertrages-gemaess-130a-abs-8-sgb-v-zwisch), checked 7 Nov 2026
- [Abschluss nicht-exklusiver Rabattvereinbarungen nach §130a Abs.8 SGB V zu verschiedenen Wirkstoff-/en/-kombinationen mit jederzeitiger Abschlussmöglichkeit im Rahmen des sog. Open House-Verfahrens](https://inteliwert.com/tender/opp_66XDJF1GBCQ9Y599M4A37GG7H3/abschluss-nicht-exklusiver-rabattvereinbarungen-nach-130a-abs-8-sgb-v-zu-verschi)  
  Open · SME (from the award notice) · New to public tenders · Buyer: AOK Nordost. Die Gesundheitskasse. · Deadline: 5 Mar 2028, 23:58 (UTC+01:00) · [Official notice](https://oeffentlichevergabe.de/ui/de/notices/16277502-ab25-4992-b8af-95a7d71ef3cc), Last checked 7 Nov 2026, 18:30 (UTC+01:00)
  - Won a contract in CPV group 336 (2026-09-16): [Evidence](https://inteliwert.com/tender/opp_8CHYVB5V4J4WJS2PESVNYQK95P/abschluss-eines-nicht-exklusiven-rabattvertrages-gemaess-130a-abs-8-sgb-v-zwisch), checked 7 Nov 2026
  - Seat in the same country as the place of performance: [Evidence](https://inteliwert.com/company/org_YRDP130JYBMX0Y189BSK381E56), checked 7 Nov 2026
  - 1 award in this field in 36 months, from 1 buyer: [Evidence](https://inteliwert.com/tender/opp_8CHYVB5V4J4WJS2PESVNYQK95P/abschluss-eines-nicht-exklusiven-rabattvertrages-gemaess-130a-abs-8-sgb-v-zwisch), checked 7 Nov 2026
- [Arzneimittelverträge mit Beitrittsoption für den Wirkstoff: Cyanocobalamin (OTC, parenteral)](https://inteliwert.com/tender/opp_T0RBJJX17374FPA23MCBAYT3KM/arzneimittelvertraege-mit-beitrittsoption-fuer-den-wirkstoff-cyanocobalamin-otc-)  
  Open · SME (from the award notice) · New to public tenders · Buyer: BARMER Beschaffung und Vergabe · Deadline: 1 Aug 2028, 12:00 (UTC+02:00) · [Official notice](https://oeffentlichevergabe.de/ui/de/notices/2c83b422-46de-4e9e-87be-fcc3c661ae36), Last checked 7 Nov 2026, 13:30 (UTC+01:00)
  - Won a contract in CPV group 336 (2026-09-16): [Evidence](https://inteliwert.com/tender/opp_8CHYVB5V4J4WJS2PESVNYQK95P/abschluss-eines-nicht-exklusiven-rabattvertrages-gemaess-130a-abs-8-sgb-v-zwisch), checked 7 Nov 2026
  - Seat in the same country as the place of performance: [Evidence](https://inteliwert.com/company/org_YRDP130JYBMX0Y189BSK381E56), checked 7 Nov 2026
  - 1 award in this field in 36 months, from 1 buyer: [Evidence](https://inteliwert.com/tender/opp_8CHYVB5V4J4WJS2PESVNYQK95P/abschluss-eines-nicht-exklusiven-rabattvertrages-gemaess-130a-abs-8-sgb-v-zwisch), checked 7 Nov 2026
- [Arzneimittel mit dem Wirkstoff Perampanel (ATC: N03AX22)](https://inteliwert.com/tender/opp_0TD45MW0AC032TDS5BDV3AHKMH/arzneimittel-mit-dem-wirkstoff-perampanel-atc-n03ax22)  
  Open · SME (from the award notice) · New to public tenders · Buyer: AOK Sachsen - Anhalt · Deadline: 31 Aug 2028, 00:00 (UTC+02:00) · [Official notice](https://oeffentlichevergabe.de/ui/de/notices/83e6e7af-860a-462c-87b3-0685b1b0814a), Last checked 7 Nov 2026, 20:30 (UTC+01:00)
  - Won a contract in CPV group 336 (2026-09-16): [Evidence](https://inteliwert.com/tender/opp_8CHYVB5V4J4WJS2PESVNYQK95P/abschluss-eines-nicht-exklusiven-rabattvertrages-gemaess-130a-abs-8-sgb-v-zwisch), checked 7 Nov 2026
  - Seat in the same country as the place of performance: [Evidence](https://inteliwert.com/company/org_YRDP130JYBMX0Y189BSK381E56), checked 7 Nov 2026
  - 1 award in this field in 36 months, from 1 buyer: [Evidence](https://inteliwert.com/tender/opp_8CHYVB5V4J4WJS2PESVNYQK95P/abschluss-eines-nicht-exklusiven-rabattvertrages-gemaess-130a-abs-8-sgb-v-zwisch), checked 7 Nov 2026

## Is this your company?

Send corrections, or ask us to remove the profile, to <hello@inteliwert.com>. You can also ask that the company never be tagged on LinkedIn.

## About this profile

Each fact on this page shows its source: a public notice, an open-data register (GLEIF, Wikidata) or the company’s own website. Inteliwert does not rate companies and does not judge eligibility, fit or chances.

**Based on the notices and sources Inteliwert covers; not a complete record.** Last checked 16 September 2026.

---

Page: https://inteliwert.com/company/org_YRDP130JYBMX0Y189BSK381E56/g-l-pharma-deutschland-gmbh

Inteliwert is a product of Bandpey GmbH, an international data and AI software company in Munich, Germany, founded and led by Roozbeh Bandpey. Bandpey's products: Facthory, Emolysis, Copolly and Inteliwert.

Inteliwert on LinkedIn: https://www.linkedin.com/company/intelliwert, GitHub: https://github.com/inteliwertai.